Sunshine Biopharma, Inc.
USD2.12
+0.01 (+0.47%)
CEO
Steve N. Slilaty
IPO Date
2022-02-15
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
CA
Open
$2.18
Prev. Close
$2.11
Day Low
$2.08
Day High
$2.18
52W Low
$2.00
52W High
$24.30
Market Cap
$0.00B
Volume
0.02M
| -0.4 |
| 31 Dec 2023 | FY | 34.6% | -18.7% | -21.2% | -16.5% | 0.03 | 4.48 | -1.5 |
| 31 Dec 2022 | FY | 39.0% | -615.4% | -123.7% | -90.5% | 0.04 | 3.94 | -0.4 |
| 31 Dec 2021 | FY | 48.4% | -5444.4% | -5875.6% | -564.6% | 8.98 | 24.07 | -0.6 |
| 31 Dec 2020 | FY | 63.8% | -3898.7% | 291.6% | -266.3% | -2.00 | 0.98 | -0.5 |
| 31 Dec 2019 | FY | 47.7% | -7860.9% | 225.8% | -1691.7% | -0.97 | 0.08 | -1.0 |
| 31 Dec 2018 | FY | 12.5% | -482.1% | 3867.3% | -188.1% | -17.09 | 0.23 | -226.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 181.4% | -404.0% | -1.40 | 0.16 | -19964.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 1667.5% | -5429.3% | -1.13 | 0.21 | 0.0 |
| -0.6 |
| 30 Sept 2025 | Q3 | 32.6% | -9.4% | -3.7% | -2.8% | 0.04 | 4.20 | -2.0 |
| 30 Jun 2025 | Q2 | 36.4% | -18.8% | -6.9% | -5.5% | 0.04 | 5.00 | -0.0 |
| 31 Mar 2025 | Q1 | 30.7% | -13.3% | -5.2% | -4.0% | 0.04 | 4.25 | -1.1 |
| 31 Dec 2024 | Q4 | 32.2% | -22.5% | -9.2% | -7.1% | 0.04 | 4.11 | -0.9 |
| 30 Sept 2024 | Q3 | 34.0% | -14.2% | -4.8% | -4.0% | 0.02 | 5.74 | -0.8 |
| 30 Jun 2024 | Q2 | 25.3% | -5.3% | -2.1% | -1.7% | 0.02 | 4.86 | -0.2 |
| 31 Mar 2024 | Q1 | 31.2% | -17.0% | -5.2% | -4.0% | 0.02 | 4.41 | -1.3 |
| 31 Dec 2023 | Q4 | 33.4% | -16.3% | -5.9% | -4.6% | 0.03 | 4.48 | -1.3 |